The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions

Qiang Yao, Krzysztof Pawlaczyk, Ernesto Rodríguez Ayala, Arkadiusz Styszynski, Andrzej Breborowicz, Olof Heimburger, Jia Qi Qian, Peter Stenvinkel, Bengt Lindholm, Jonas Axelsson

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Peritoneal dialysis (PD) solutions contribute to peritoneal membrane damage. We investigated how conventional and biocompatible PD solutions with different glucose concentrations affect morphological and functional signs of peritoneal fibrosis as well as the TGF-β1/Smad signaling pathway in a chronic PD rat model. Methods: Non-uremic male Wistar rats (n = 28) were dialyzed thrice daily for 28 days with 20 ml of a conventional solution (Dianeal® 1.36%, D1, or 3.86%, D3) or a biocompatible solution (Physioneal® 1.36%, P1, or 3.86%, P3). A peritoneal equilibration test was performed. Six rats without dialysis served as controls. Results: The use of conventional solutions, particularly D3, resulted in expansion of the submesothelial compact zone, loss of mesothelial cell layer integrity, hypercellularity, accumulation of collagen I, increased vessel numbers and increased TGF-β1/Smad expression, but this did not significantly change fluid and solute peritoneal transport characteristics. In comparison with D1 and D3, the use of P1 and P3 was associated with less TGF-β1/Smad expression and less expansion of the submesothelial cell layer. Conclusions: Our findings indicate that biocompatible solutions with less glucose may decrease the rate of peritoneal fibrosis. The TGF-β1/Smad pathway is stimulated by PD solutions, representing a plausible pathophysiological mechanism.

Original languageEnglish (US)
JournalNephron - Experimental Nephrology
Volume109
Issue number2
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Peritoneal Fibrosis
Dialysis Solutions
Peritoneal Dialysis
Glucose
Ascitic Fluid
Wistar Rats
Dialysis
Collagen
Membranes

Keywords

  • Angiogenesis
  • Collagen
  • Dialysis solutions
  • Fibrosis
  • Peritoneal dialysis rat model
  • Ultrafiltration

ASJC Scopus subject areas

  • Nephrology

Cite this

Yao, Q., Pawlaczyk, K., Ayala, E. R., Styszynski, A., Breborowicz, A., Heimburger, O., ... Axelsson, J. (2008). The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron - Experimental Nephrology, 109(2). https://doi.org/10.1159/000142529

The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. / Yao, Qiang; Pawlaczyk, Krzysztof; Ayala, Ernesto Rodríguez; Styszynski, Arkadiusz; Breborowicz, Andrzej; Heimburger, Olof; Qian, Jia Qi; Stenvinkel, Peter; Lindholm, Bengt; Axelsson, Jonas.

In: Nephron - Experimental Nephrology, Vol. 109, No. 2, 07.2008.

Research output: Contribution to journalArticle

Yao, Q, Pawlaczyk, K, Ayala, ER, Styszynski, A, Breborowicz, A, Heimburger, O, Qian, JQ, Stenvinkel, P, Lindholm, B & Axelsson, J 2008, 'The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions', Nephron - Experimental Nephrology, vol. 109, no. 2. https://doi.org/10.1159/000142529
Yao, Qiang ; Pawlaczyk, Krzysztof ; Ayala, Ernesto Rodríguez ; Styszynski, Arkadiusz ; Breborowicz, Andrzej ; Heimburger, Olof ; Qian, Jia Qi ; Stenvinkel, Peter ; Lindholm, Bengt ; Axelsson, Jonas. / The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. In: Nephron - Experimental Nephrology. 2008 ; Vol. 109, No. 2.
@article{0dfe037cbfc44efd8b10209158edf41f,
title = "The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions",
abstract = "Background: Peritoneal dialysis (PD) solutions contribute to peritoneal membrane damage. We investigated how conventional and biocompatible PD solutions with different glucose concentrations affect morphological and functional signs of peritoneal fibrosis as well as the TGF-β1/Smad signaling pathway in a chronic PD rat model. Methods: Non-uremic male Wistar rats (n = 28) were dialyzed thrice daily for 28 days with 20 ml of a conventional solution (Dianeal{\circledR} 1.36{\%}, D1, or 3.86{\%}, D3) or a biocompatible solution (Physioneal{\circledR} 1.36{\%}, P1, or 3.86{\%}, P3). A peritoneal equilibration test was performed. Six rats without dialysis served as controls. Results: The use of conventional solutions, particularly D3, resulted in expansion of the submesothelial compact zone, loss of mesothelial cell layer integrity, hypercellularity, accumulation of collagen I, increased vessel numbers and increased TGF-β1/Smad expression, but this did not significantly change fluid and solute peritoneal transport characteristics. In comparison with D1 and D3, the use of P1 and P3 was associated with less TGF-β1/Smad expression and less expansion of the submesothelial cell layer. Conclusions: Our findings indicate that biocompatible solutions with less glucose may decrease the rate of peritoneal fibrosis. The TGF-β1/Smad pathway is stimulated by PD solutions, representing a plausible pathophysiological mechanism.",
keywords = "Angiogenesis, Collagen, Dialysis solutions, Fibrosis, Peritoneal dialysis rat model, Ultrafiltration",
author = "Qiang Yao and Krzysztof Pawlaczyk and Ayala, {Ernesto Rodr{\'i}guez} and Arkadiusz Styszynski and Andrzej Breborowicz and Olof Heimburger and Qian, {Jia Qi} and Peter Stenvinkel and Bengt Lindholm and Jonas Axelsson",
year = "2008",
month = "7",
doi = "10.1159/000142529",
language = "English (US)",
volume = "109",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions

AU - Yao, Qiang

AU - Pawlaczyk, Krzysztof

AU - Ayala, Ernesto Rodríguez

AU - Styszynski, Arkadiusz

AU - Breborowicz, Andrzej

AU - Heimburger, Olof

AU - Qian, Jia Qi

AU - Stenvinkel, Peter

AU - Lindholm, Bengt

AU - Axelsson, Jonas

PY - 2008/7

Y1 - 2008/7

N2 - Background: Peritoneal dialysis (PD) solutions contribute to peritoneal membrane damage. We investigated how conventional and biocompatible PD solutions with different glucose concentrations affect morphological and functional signs of peritoneal fibrosis as well as the TGF-β1/Smad signaling pathway in a chronic PD rat model. Methods: Non-uremic male Wistar rats (n = 28) were dialyzed thrice daily for 28 days with 20 ml of a conventional solution (Dianeal® 1.36%, D1, or 3.86%, D3) or a biocompatible solution (Physioneal® 1.36%, P1, or 3.86%, P3). A peritoneal equilibration test was performed. Six rats without dialysis served as controls. Results: The use of conventional solutions, particularly D3, resulted in expansion of the submesothelial compact zone, loss of mesothelial cell layer integrity, hypercellularity, accumulation of collagen I, increased vessel numbers and increased TGF-β1/Smad expression, but this did not significantly change fluid and solute peritoneal transport characteristics. In comparison with D1 and D3, the use of P1 and P3 was associated with less TGF-β1/Smad expression and less expansion of the submesothelial cell layer. Conclusions: Our findings indicate that biocompatible solutions with less glucose may decrease the rate of peritoneal fibrosis. The TGF-β1/Smad pathway is stimulated by PD solutions, representing a plausible pathophysiological mechanism.

AB - Background: Peritoneal dialysis (PD) solutions contribute to peritoneal membrane damage. We investigated how conventional and biocompatible PD solutions with different glucose concentrations affect morphological and functional signs of peritoneal fibrosis as well as the TGF-β1/Smad signaling pathway in a chronic PD rat model. Methods: Non-uremic male Wistar rats (n = 28) were dialyzed thrice daily for 28 days with 20 ml of a conventional solution (Dianeal® 1.36%, D1, or 3.86%, D3) or a biocompatible solution (Physioneal® 1.36%, P1, or 3.86%, P3). A peritoneal equilibration test was performed. Six rats without dialysis served as controls. Results: The use of conventional solutions, particularly D3, resulted in expansion of the submesothelial compact zone, loss of mesothelial cell layer integrity, hypercellularity, accumulation of collagen I, increased vessel numbers and increased TGF-β1/Smad expression, but this did not significantly change fluid and solute peritoneal transport characteristics. In comparison with D1 and D3, the use of P1 and P3 was associated with less TGF-β1/Smad expression and less expansion of the submesothelial cell layer. Conclusions: Our findings indicate that biocompatible solutions with less glucose may decrease the rate of peritoneal fibrosis. The TGF-β1/Smad pathway is stimulated by PD solutions, representing a plausible pathophysiological mechanism.

KW - Angiogenesis

KW - Collagen

KW - Dialysis solutions

KW - Fibrosis

KW - Peritoneal dialysis rat model

KW - Ultrafiltration

UR - http://www.scopus.com/inward/record.url?scp=48249109924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249109924&partnerID=8YFLogxK

U2 - 10.1159/000142529

DO - 10.1159/000142529

M3 - Article

C2 - 18600031

AN - SCOPUS:48249109924

VL - 109

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 2

ER -